An open clinical trial of a Siddha formulation Kandhaga rasayanam in ringworm infection.
Phase 2
Completed
- Conditions
- Health Condition 1: B359- Dermatophytosis, unspecifiedHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissueHealth Condition 3: null- tinea infection
- Registration Number
- CTRI/2012/01/002362
- Lead Sponsor
- national institute of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients clinically diagnosed with tinea infection (tinea pedis, cruris, corporis, capitis, barbae, mannum ,ungium.).
Patients of both sexes. Patients between 18 years to 60 years of age.
Ability to understand and sign the informed consent.
Direct microscopic examination of the skin scraping which shows positive for dermatophytes.
Exclusion Criteria
Pregnant women or nursing mother.
Use of other topical or oral antifungal drugs, immunosuppressive drugs, anthelmintic drugs either currently or during the 2 weeks preceding initiation of drug trial.
Allergy or hypersensitivity of any component of the drug.
Clinical case of Eczema, Psoriasis, Lichen planus, Pityriasis versicolor, Drug induced eruptions, Urticaria, Intertrigo.
Diabetic patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method skin scrapping test negative for dermatophytesTimepoint: skin scrapping test negative for dermatophytes
- Secondary Outcome Measures
Name Time Method relief from itching,burning sensation, ooze, vesicles, putules, hyperkeratosis etcTimepoint: 45 days